4//SEC Filing
Bjarke Henric Bjorn 4
Accession 0001209191-21-003595
CIK 0001693011other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:16 PM ET
Size
5.6 KB
Accession
0001209191-21-003595
Insider Transaction Report
Form 4
Bjarke Henric Bjorn
See Remarks
Transactions
- Award
Stock Option (right to buy)
2021-01-13+51,105→ 51,105 totalExercise: $2.77Exp: 2030-04-22→ Common Stock (51,105 underlying)
Footnotes (1)
- [F1]This option was granted on April 23, 2020, with vesting subject to the satisfaction of performance based vesting criteria. The performance based vesting criteria were satisfied on January 13, 2021 and the shares underlying the option vest in equal monthly installments from April 23, 2020 through April 23, 2024.
Documents
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001652179
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 4:16 PM ET
- Size
- 5.6 KB